HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).

Abstract
The MHC class II transactivator (CIITA) is the master regulator for HLA-D (DP, DQ, DR) gene expression. In this report the coding and promoter regions of the CIITA gene, MHC2TA, were evaluated for polymorphisms in 50 normal Caucasian individuals. Allele frequencies were obtained for four separate single nucleotide (nt) polymorphisms (SNPs) identified in the MHC2TA coding region: nt 1614 (C-->G), nt 2509 (G-->A), nt 2536 (T-->G), and nt 2791 (G-->A). MHC2TA sequence analysis of 100 chromosomes from these 50 individuals revealed a SNP in MHC2TA promoter (p) III at nt (-)155 (A-->G), but none in CIITA pI or pIV. In addition, we demonstrate the presence of splice variant at a previously undiscovered intron, accounting for a three nt (TAG) insertion at position 474 that was originally described in association with one of the disease-causing CIITA cDNA mutations in bare lymphocyte syndrome.
AuthorsJ C Patarroyo, O Stuve, J F Piskurich, S L Hauser, J R Oksenberg, S S Zamvil
JournalGenes and immunity (Genes Immun) Vol. 3 Issue 1 Pg. 34-7 (Feb 2002) ISSN: 1466-4879 [Print] England
PMID11857059 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • MHC class II transactivator protein
  • Nuclear Proteins
  • Trans-Activators
Topics
  • Alternative Splicing
  • Base Sequence
  • Chromosome Mapping
  • Gene Frequency
  • Genes, MHC Class II
  • Humans
  • Introns
  • Molecular Sequence Data
  • Mutation
  • Nuclear Proteins
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic
  • Trans-Activators (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: